First Time Loading...

Clovis Oncology Inc
NASDAQ:CLVS

Watchlist Manager
Clovis Oncology Inc Logo
Clovis Oncology Inc
NASDAQ:CLVS
Watchlist
Price: 0.093 USD 3.33% Market Closed
Updated: May 23, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

346.8m
-12%
Assets
Growth Rates:
1 Year
-32%
3 Years
-52%
5 Years
-57%
7 Years
-61%
10 Years
-
764.7m
+0.5%
Liabilities
Growth Rates:
1 Year
+4%
3 Years
-5%
5 Years
+51%
7 Years
+60%
10 Years
-
-417.9m
-14%
Equity
Growth Rates:
1 Year
-85%
3 Years
-378%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Clovis Oncology Inc

346.8m
Assets
764.7m
Liabilities
346.8m
Assets
764.7m
Liabilities
Current Assets 102.2m
Cash & Short-Term Investments 58.3m
Receivables 22.6m
Other Current Assets 21.3m
Non-Current Assets 244.6m
PP&E 21.5m
Intangibles 119.4m
Other Non-Current Assets 103.6m
Current Liabilities 747.9m
Accounts Payable 18.1m
Accrued Liabilities 68.8m
Other Current Liabilities 661m
Non-Current Liabilities 16.8m
Other Non-Current Liabilities 16.8m

Balance Sheet
Clovis Oncology Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021
Assets
Cash & Cash Equivalents
144
323
483
279
216
464
222
162
240
143
Cash Equivalents
144
323
483
279
216
464
222
162
240
143
Short-Term Investments
0
0
0
250
50
100
298
135
0
0
Total Receivables
0
4
2
5
3
8
15
35
31
34
Accounts Receivables
0
0
0
0
0
6
13
21
27
27
Other Receivables
0
0
0
0
3
2
2
14
4
7
Inventory
0
0
0
0
0
28
27
27
31
14
Other Current Assets
1
2
6
6
10
27
10
9
9
7
Total Current Assets
145
329
491
540
279
627
572
367
311
198
PP&E Net
1
1
3
5
4
4
27
43
43
26
PP&E Gross
1
1
3
5
0
4
27
43
43
26
Accumulated Depreciation
1
1
1
2
0
4
5
8
11
11
Intangible Assets
0
245
213
102
21
20
52
63
66
60
Goodwill
0
75
66
59
57
65
63
63
63
63
Other Long-Term Assets
0
1
5
8
3
20
150
134
123
126
Other Assets
0
75
66
59
57
65
63
63
63
63
Total Assets
146
N/A
650
+345%
777
+20%
713
-8%
365
-49%
735
+102%
864
+17%
670
-22%
606
-10%
473
-22%
Liabilities
Accounts Payable
2
4
3
11
11
15
29
32
27
27
Accrued Liabilities
10
17
45
64
55
44
95
97
93
88
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
1
0
64
9
Other Current Liabilities
0
0
0
0
20
22
1
4
1
2
Total Current Liabilities
12
21
48
76
86
82
126
133
185
125
Long-Term Debt
0
0
279
280
281
282
576
680
546
607
Deferred Income Tax
0
75
67
31
0
0
0
0
0
0
Other Liabilities
0
56
53
26
1
4
16
31
34
20
Total Liabilities
13
N/A
152
+1 114%
446
+194%
413
-7%
368
-11%
368
0%
717
+95%
844
+18%
764
-9%
752
-2%
Equity
Common Stock
0
0
0
0
0
0
0
0
0
0
Retained Earnings
185
269
429
782
1 131
1 477
1 843
2 244
2 613
2 877
Additional Paid In Capital
318
762
785
1 130
1 175
1 887
2 034
2 114
2 498
2 642
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Other Equity
0
5
24
47
47
42
45
45
44
43
Total Equity
134
N/A
498
+273%
332
-33%
301
-9%
4
N/A
368
N/A
147
-60%
174
N/A
159
+9%
279
-76%
Total Liabilities & Equity
146
N/A
650
+345%
777
+20%
713
-8%
365
-49%
735
+102%
864
+17%
670
-22%
606
-10%
473
-22%
Shares Outstanding
Common Shares Outstanding
26
34
34
38
39
51
53
55
104
129

See Also

Summary
CLVS intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLVS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLVS stock valuation using valuation multiples.
Wall Street Estimates
CLVS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLVS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 140,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.